Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
I. Romito, M. Porru, M. R. Braghini, Luca Pompili, N. Panera, A. Crudele, D. Gnani, C. De Stefanis, M. Scarsella, S. Pomella, Stefano Levi Mortera, Emmanuel de Billy, Adrian Libenzio Conti, V. Marzano, L. Putignani, M. Vinciguerra, C. Balsano, A. Pastore, R. Rota, M. Tartaglia, C. Leonetti, A. Alisi
Journal of experimental & clinical cancer research : CR